Intestinal mucosal barrier function in health and disease
By J. Turner. Nature reviews. Immunology, 2009
3,618 citations recorded by the source corpus.
Subfields: Molecular Biology, Neurology, Surgery
View Paper: https://www.semanticscholar.org/paper/7032b5cfc31d0560d14b7bb7662b93a9d838a2e8
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Molecular Biology
- Curtis Huttenhower
- Nicola Segata
- K. Honda
- Dan R. Littman
- Levi Waldron
- Dirk Gevers
- W. Garrett
- J. Turner
In Neurology
- K. Honda
- Dan R. Littman
- Takuya Suzuki
- Sung Hee Lee
- Geoffrey D. Miller
- Carol S. Lim
- B. Bruno
- A. Buckley
In Surgery
- Dan R. Littman
- Takuya Suzuki
- K. Honda
- Sung Hee Lee
- Geoffrey D. Miller
- Carol S. Lim
- B. Bruno
- A. Buckley
Citations in the corpus
- Akkermansia Muciniphila Protects Against Atherosclerosis by Preventing Metabolic Endotoxemia-Induced Inflammation in Apoe −/− Mice (2016, background): “Penetration of lipopolysaccharide into the bloodstream is controlled by the integrity of the gut barrier.48 Administration of A muciniphila has been shown to prevent the thinning of mucus layer in mice with diet-induced obesity.21 The mucus layer is enriched with various mucins that form a hydrated ”
- Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus (2011, background): “2131" language="eng" relation="no"> The maintenance of epithelial barrier function at mucosal sites such as the intestine and respiratory tract is critical for limiting exposure to environmental stimuli, commensal bacteria and invading pathogen”
- Intestinal Permeability Regulation by Tight Junction: Implication on Inflammatory Bowel Diseases (2015, background): “org to be important in the initiation and/or development of several intestinal and systemic diseases.(1,10) In contrast, some growth factors play roles in protection and maintenance of TJ integrity.”
- Tight Junction Pore and Leak Pathways: A Dynamic Duo (2011, background): “The clinical significance of intestinal barrier dysfunction has been the topic of numerous recent reviews and commentaries (14, 94, 113) and is not detailed here.”
- Metagenomic biomarker discovery and explanation (2011, methodology): “from the Human Microbiome Project [55,56] assigning the main body sites to mucosal and non-mucosal classes, and using the body sites as”
- Basics and recent advances in peptide and protein drug delivery (2013, positive): “Once a molecule passes the mucosal layer, however, the unstirred layer may act as an absorption enhancer by allowing the particle more time exposed to the epithelial barrier [21].”
- Symbiotic Bacterial Metabolites Regulate Gastrointestinal Barrier Function via the Xenobiotic Sensor PXR and Toll-like Receptor 4 (2014, positive): “…intestinal barrier function has been implicated in the pathogenesis of several disease states (e.g., type I diabetes, asthma, autism, acne, allergies etc.) including inflamatory bowel disease (IBD) (Gummesson et al., 2011; Islam and Luster, 2012; Mayer, 2011; Meier and Plevy, 2007; Turner, 2009).”
- Lipopolysaccharide causes an increase in intestinal tight junction permeability in vitro and in vivo by inducing enterocyte membrane expression and localization of TLR-4 and CD14. (2013, background): “An integral function of intestinal epithelial cells is to act as a physical barrier, separating the noxious luminal environment from the underlying lamina propria and the deeper intestinal layers.(1,2) The apically located tight junctions (TJs) form a paracellular seal between the lateral membranes ”
- The intestinal barrier: a fundamental role in health and disease (2017, background): “The gastrointestinal (GI) tract harbors one of the largest luminal interaction areas of these barriers, and plays a pivotal role in the regulation of the immune system, and hence in health [1,2].”